Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. Issue 9 (29th July 2022)

Record Type:: Journal Article
Title:: Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. Issue 9 (29th July 2022)
Main Title:: Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
Authors:: Kuo, Alyce M.
Hassoun, Hani
Shah, Urvi
Gordon, Allison
Hollmann, Travis J.
Landau, Heather J.
Lezcano, Cecilia
Mailankody, Sham
Tan, Carlyn C.
Lesokhin, Alexander M.
Markova, Alina
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 63:Issue 9(2022)
Journal:: Leukemia & lymphoma
Issue:: Volume 63:Issue 9(2022)
Issue Display:: Volume 63, Issue 9 (2022)
Year:: 2022
Volume:: 63
Issue:: 9
Issue Sort Value:: 2022-0063-0009-0000
Page Start:: 2233
Page End:: 2237
Publication Date:: 2022-07-29
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2022.2068002 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24038.xml